(Q39640366)

13 September 2017

title

Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue (English)

1 reference

13 September 2017

1 reference

1 reference

15

Karin Milde-Langosch

1 reference

13 September 2017

Sibyll Hein

1

1 reference

13 September 2017

Volkmar Müller

2

1 reference

13 September 2017

Nadine Köhler

3

1 reference

13 September 2017

Harriet Wikman

4

1 reference

13 September 2017

Sylke Krenkel

5

1 reference

13 September 2017

Thomas Streichert

6

1 reference

13 September 2017

Michaela Schweizer

7

1 reference

13 September 2017

Sabine Riethdorf

8

1 reference

13 September 2017

Volker Assmann

9

1 reference

13 September 2017

Maike Ihnen

10

1 reference

13 September 2017

Katrin Beck

11

1 reference

13 September 2017

Rana Issa

12

1 reference

13 September 2017

Fritz Jänicke

13

1 reference

13 September 2017

Klaus Pantel

14

1 reference

13 September 2017

language of work or name

English

0 references

publication date

23 October 2010

1 reference

Breast Cancer Research and Treatment

13 September 2017

published in

1 reference

13 September 2017

volume

129

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

347-360

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-1219-y

13 September 2017

exact match

0 references

cites work

Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

ALCAM (CD166): its role in hematopoietic and endothelial development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

A role for Runx2 in normal mammary gland and breast cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/ progenitor cell protein profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Ets2 transcription factor in normal and neoplastic human breast tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Unraveling the complexity of endocrine resistance in breast cancer by functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

The adhesion molecule L1 (CD171) promotes melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

Subcellular Localization of Activated Leukocyte Cell Adhesion Molecule Is a Molecular Predictor of Survival in Ovarian Carcinoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1219-Y

10.1007/S10549-010-1219-Y

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference